-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WYHTF/wq9acmKLEuoItvcUaNiTIt/jA9yF7r/o3FLNnMsGQaniXnZcYNyVxbggaf FU4D1LS4JhsDWiqxp9cgeA== 0001391914-09-000005.txt : 20091203 0001391914-09-000005.hdr.sgml : 20091203 20091203170549 ACCESSION NUMBER: 0001391914-09-000005 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 ITEM INFORMATION: Securities Act Section 4(6) FILED AS OF DATE: 20091203 DATE AS OF CHANGE: 20091203 EFFECTIVENESS DATE: 20091203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AIKO BIOTECHNOLOGY INC CENTRAL INDEX KEY: 0001391914 IRS NUMBER: 205556662 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-100679 FILM NUMBER: 091220758 BUSINESS ADDRESS: STREET 1: 2 UNION STREET STREET 2: SUITE 501 CITY: PORTLAND STATE: ME ZIP: 04101 BUSINESS PHONE: 207-879-2221 MAIL ADDRESS: STREET 1: 2 UNION STREET STREET 2: SUITE 501 CITY: PORTLAND STATE: ME ZIP: 04101 D/A 1 primary_doc.xml X0603 D/A LIVE 0001391914 AIKO BIOTECHNOLOGY INC 2 UNION STREET SUITE 501 PORTLAND ME 04101 207-879-2221 DELAWARE None None Corporation true 2006 Victor C. Otley, III 2 Union Street Suite 501 Portland ME 04101 Executive Officer Director Promoter Wolfgang Sadee 2 Union Street Suite 501 Portland ME 04101 Executive Officer Director Promoter William Emheiser 2 Union Street Suite 501 Portland ME 04101 Executive Officer Promoter David Anderson 2 Union Street Suite 501 Portland ME 04101 Director Edward Bilsky 2 Union Street Suite 501 Portland ME 04101 Director Janet Yancey-Wrona 2 Union Street Suite 501 Portland ME 04101 Executive Officer Promoter Pharmaceuticals No Revenues 06 46 true 9999999997-07-008626 2009-11-05 false true false 0 850000 850000 0 Conversion of principal and interest in aggregate amount of approximately $850,000. false 0 0 0 0 No cash proceeds from conversion. false AIKO BIOTECHNOLOGY INC Margaret Callaghan Margaret Callaghan Authorized Attorney 2009-12-03 -----END PRIVACY-ENHANCED MESSAGE-----